Publications by authors named "I Toshkov"

Claim this Profile
F
FACT maintains nucleosomes during transcription and stem cell viability in adult mice.
Imon Goswami, Poorva Sandlesh, Aimee Stablewski, Ilya Toshkov, Alfiya F Safina

EMBO Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.
Vadim Mett, Oleg V Kurnasov, Ivan A Bespalov, Ivan Molodtsov, Craig M Brackett, Ilia A Toshkov

Commun Biol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
L Cheng, Z Zhou, A Flesken-Nikitin, I A Toshkov, W Wang

Oncogene· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects.
Gary J Haderski, Bojidar M Kandar, Craig M Brackett, Ilia M Toshkov, Christopher P Johnson

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Marina P Antoch, Michelle Wrobel, Bryan Gillard, Karen K Kuropatwinski, Ilia Toshkov

Oncotarget· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis